| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-08 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-08 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-07 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 7e-05 |